Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer

Koji Okabayashi, Tomonobu Fujita, Junichiro Miyazaki, Tsutomu Okada, Takashi Iwata, Nobumaru Hirao, Shinobu Noji, Nobuo Tsukamoto, Naoki Goshima, Hirotoshi Hasegawa, Hiroya Takeuchi, Masakazu Ueda, Yuko Kitagawa, Yutaka Kawakami

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences